Skip to main content
Shenzhen Vital New Material Co.,Ltd. logo

Shenzhen Vital New Material Co.,Ltd. — Investor Relations & Filings

Ticker · 301319 ISIN · CNE100005L76 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 488 across all filing types
Latest filing 2026-05-25 Major Shareholding Noti…
Country CN China
Listing Shenzhen Stock Exchange 301319

About Shenzhen Vital New Material Co.,Ltd.

https://www.szvital.com

Shenzhen Vital New Material Co., Ltd. specializes in the research, development, and manufacturing of advanced electronic soldering materials. The product portfolio includes high-performance solder pastes, solder wires, solder bars, and liquid fluxes designed for diverse assembly requirements. These materials are engineered for applications in consumer electronics, automotive systems, telecommunications, and industrial automation. The company focuses on providing lead-free and halogen-free solutions that meet international environmental standards such as RoHS and REACH. By leveraging sophisticated production technologies and rigorous quality control, the company delivers high-reliability materials suitable for fine-pitch SMT processes and complex soldering environments. Technical expertise supports the evolving needs of global electronics manufacturing services (EMS) through customized material formulations and process optimization.

Recent filings

Filing Released Lang Actions
关于持股5%以上股东权益变动触及 1%整数倍的提示性公告
Major Shareholding Notification Classification · 95% confidence The document is an announcement titled “关于持股5%以上股东权益变动触及1%整数倍的提示性公告,” describing changes in shareholding percentage by a shareholder holding over 5% and notification that it has crossed a 1% threshold. This matches the definition of a Major Shareholding Notification (MRQ).
2026-05-25 Chinese
股票交易严重异常波动公告
Regulatory Filings Classification · 85% confidence The document is a formal stock exchange announcement regarding “serious abnormal fluctuations” in the company’s share price and provides explanations, investor warnings, and compliance with Shenzhen Stock Exchange rules. It is not a financial report, earnings release, or corporate action (such as dividends, capital changes, or M&A), nor is it a proxy, audit, or board change notice. It is a regulatory disclosure of an abnormal trading event, which falls under the catch-all category for general regulatory announcements that do not fit more specific filing types. Therefore, it should be classified as Regulatory Filings (RNS).
2026-05-20 Chinese
广东华商律师事务所关于深圳市唯特偶新材料股份有限公司调整2024年股票期权激励计划行权价格及授予数量的法律意见书
Regulatory Filings Classification · 85% confidence The document is a standalone legal opinion letter issued by a law firm on adjustments to a 2024 stock option incentive plan (exercise price and grant quantity). It contains legal analysis, references to board and shareholder approvals, regulatory rules, and tables of calculated adjustments. It is not an earnings release, financial report, M&A document, nor a proxy or dividend notice. It serves as a compliance/legal opinion document rather than substantive financial statements. Under the taxonomy, such a legal opinion letter (a compliance/legal document) defaults to “Regulatory Filings” (RNS).
2026-05-20 Chinese
关于部分募投项目新增实施主体、实施地点及使用自有资金支付部分募投项目并以募集资金等额置换的公告
Capital/Financing Update Classification · 80% confidence The document is a corporate announcement detailing adjustments to the implementation entities and locations for IPO-raised fund investment projects (“募投项目”), and the use of own funds to temporarily finance these projects with an equivalent replacement from raised proceeds. It is not an annual or interim report, call transcript, director’s dealing, dividend notice, or proxy material, but rather a disclosure regarding the use and management of capital raised via the company’s IPO. This fits the “Capital/Financing Update” category (CAP).
2026-05-20 Chinese
关于调整2024年股票期权激励计划行权价格及授予数量的公告
Regulatory Filings Classification · 85% confidence The document is a regulatory announcement by Shenzhen Vito New Materials Co., Ltd. concerning adjustments to its 2024 stock option incentive plan’s exercise price and grant quantities. It describes board and shareholder approvals, legal opinions, adjustment formulas and results, but does not contain full financial statements, fundraising details, or exec‐level compensation breakdowns intended for a proxy statement. Instead, it is a standalone corporate disclosure under Shenzhen exchange rules. There is no dedicated category for equity incentive plan announcements, so it falls into the general “Regulatory Filings” bucket.
2026-05-20 Chinese
第六届董事会第十次会议决议公告
Regulatory Filings Classification · 58% confidence The document is a public announcement of board resolutions from the Sixth Board’s 10th meeting, detailing project approvals, funding arrangements, and share option adjustments. It contains no financial statements (so not an Interim or Annual Report), no director appointments or resignations (so not MANG), no dividend notice, financing update, or M&A. It is a general regulatory announcement of board decisions and thus falls into the fallback category Regulatory Filings (RNS).
2026-05-20 Chinese

Browse filings by year

5 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.